| name | icsm-hypogonadism-diagnosis-confirmation |
| description | This skill confirms the diagnosis of male hypogonadism by requiring both characteristic clinical symptoms and consistently low total testosterone levels on two separate morning measurements. It is triggered when a clinician evaluates a patient with suspected hypogonadism and wonders whether low testosterone and symptoms are present or if the diagnosis should be confirmed. |
Confirm diagnosis of male hypogonadism
STEP 1 — Gather Information
Collect a focused history for hypogonadism symptoms: sexual (low libido, decreased nocturnal/morning erections, erectile dysfunction) and non‑specific (fatigue, low energy, depressed mood, hot flushes, decreased vigor). Obtain a morning fasting total testosterone (tT) sample between 07:00–11:00 h using a reliable assay.
STEP 2 — Rule In / Rule Out
Are any hypogonadism‑suggestive symptoms present? If no, rule out hypogonadism and consider alternative explanations. If yes, proceed to testosterone measurement.
STEP 3 — Classify or Stratify
Is the initial tT <12 nmol/L (≈350 ng/dL)? If ≥12 nmol/L, rule out hypogonadism. If <12 nmol/L, repeat tT on a separate day (morning fasting). If the repeat tT is ≥12 nmol/L, rule out hypogonadism; if both measurements are <12 nmol/L, proceed to diagnosis.
STEP 4 — Decide
Diagnose male hypogonadism and initiate evaluation for underlying etiology (primary, secondary, functional) while discussing potential benefits and risks of testosterone therapy.
Clinical Guardrails / Mimics / Pitfalls
Do not diagnose based on a single low testosterone result; avoid screening asymptomatic men; do not draw samples during acute illness or non‑fasting states; remember that obesity, insulin resistance, and altered SHBG can affect total testosterone interpretation; prevent overdiagnosis by requiring both symptoms and biochemical confirmation.
Concrete Clinical Example
A 48‑year‑man reports reduced libido, morning erections, and fatigue. Initial tT at 09:00 h fasting is 10.8 nmol/L; repeat tT four weeks later is 11.2 nmol/L. Both values are <12 nmol/L and symptoms are present, so male hypogonadism is confirmed.
Source: Male hypogonadism: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024), Mohit Khera et al., 2025, https://doi.org/10.1093/sxmrev/qeaf036
